Insider Transactions Reported by 5 Insiders of Theriva Biologics, Inc.

Symbol
TOVX on NYSE
Location
Rockville, MD

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

Theriva Biologics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John J. Monahan Director 05 Jan 2026
Steven A. Shallcross CEO and CFO, Director 05 Jan 2026
Jeffrey Alan Wolf Director 05 Jan 2026
Jeffrey J. Kraws Director 05 Jan 2026
Francis Tufaro Chief Operating Officer 15 Dec 2022

Recent Insider Transactions by Companies or Individuals for Theriva Biologics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Steven A. Shallcross TOVX Stock Options (right to buy) Award 475,000 475,000 05 Jan 2026 Direct
John J. Monahan TOVX Stock Options (right to buy) Award 75,000 75,000 05 Jan 2026 Direct
Jeffrey J. Kraws TOVX Stock Options (right to buy) Award 75,000 75,000 05 Jan 2026 Direct
Jeffrey Alan Wolf TOVX Stock Options (right to buy) Award 75,000 75,000 05 Jan 2026 Direct
Jeffrey Alan Wolf TOVX Stock Options (right to buy) Award 25,000 25,000 29 Apr 2025 Direct
Steven A. Shallcross TOVX Stock Options (right to buy) Award 190,000 190,000 29 Apr 2025 Direct
John J. Monahan TOVX Stock Options (right to buy) Award 25,000 25,000 29 Apr 2025 Direct
Jeffrey J. Kraws TOVX Stock Options (right to buy) Award 25,000 25,000 29 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.